Carrie Eglinton Manner has served as a director of Repligen since June 2020. She brings to the director role over 30 years of leadership experience across advanced diagnostics, clinical laboratory services and global healthcare technology. Ms. Eglinton Manner has served as President and CEO and a director of OraSure Technologies, Inc. since 2022.
Prior to OraSure, Ms. Eglinton Manner served as Senior Vice President, Advanced & General Diagnostics and Clinical Solutions at Quest Diagnostics from 2017 to 2022. At Quest, she oversaw value creation across the company's $10 billion clinical portfolio, driving innovation in R&D along with partnerships and acquisitions, and helped accelerate growth in Quest's $2 billion Advanced Diagnostics portfolio.
Prior to Quest, Ms. Eglinton Manner spent two decades at GE Healthcare building deep healthcare, commercial, operational and regulated manufacturing expertise. She served as President and CEO of four distinct global businesses ranging from $150 million to $3 billion in revenue. Ms. Eglinton Manner holds a B.S. in Mechanical Engineering from the University of Notre Dame.